Remove Manufacturing Remove Neurotransmitters and mental health Remove Pharmaceuticals
article thumbnail

The Editorial Demise of Psychotherapy and Psychosomatics Is Bad News For Us All

Mad in America

The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. Indeed, a search of Mad in America turns up 102 references to this journal.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

Joanna Moncrieff, Chemically Imbalanced (2025) E stablishment psychiatry has recently switched the biological cause of mental illness from a chemical imbalance to a brain circuitry defect. Establishment psychiatry has shown this same unscientific thinking in its manufacturing of other biological theories of mental illness.